m+Medelevator.RU
← Поиск публикаций
Biochemistry and biophysics reports · 2025

Investigating the ABTS-based antioxidant potential and antiproliferative activity of pulp, skin and seeds extracts from Nephelium lappaceum, Manilkara zapota, and Meliccocus oliviformis on human prostate and colon cancer cells.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Escobar-Ramírez Adelma, González Garrido José A, Hernández Abreu Oswaldo, Zenteno Edgar, Solórzano Mata Carlos J, Pérez Cervera Yobana, Lefebvre Tony, Dehennaut Vanessa

Аннотация

Despite significant advancements in cancer treatments, cancer remains the second leading cause of death worldwide, creating a pressing need for effective and non-toxic therapies. Plant bioactive compounds, particularly phenolic acids, have shown promising antioxidant and anticancer properties. In this study, we investigated the antioxidant potential and antiproliferative activity of methanolic extracts obtained from the skin, pulp, and seeds of three exotic fruits commonly consumed in Mexico: Manilkara zapota, Nephelium lappaceum, and Meliccocus oliviformis. The antioxidant activity was assessed using the ABTS radical scavenging assay, and total phenolic content was quantified by a modified Folin-Ciocalteu method. Most extracts exhibited significant ABTS radical scavenging capacity, with the highest phenolic content detected in the skin and seeds of N. lappaceum. and M. oliviformis. Cytotoxic and antiproliferative effects were evaluated on human colon (HCT116) and prostate (DU145) cancer cell lines. The skin of N. lappaceum and the seeds of M. zapota and M. oliviformis showed strong antiproliferative activity. These findings highlight the therapeutic potential of underutilized fruit by-products and support further investigation into their bioactive constituents as complementary candidates for cancer treatment.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты